Inventor
HARATS DROR
IL31 patents
⚠️ This page may combine multiple inventors who share the name “HARATS DROR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VASCULAR BIOGENICS LTD
15 patentsUS7973023B2Jul 5, 2011
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
VASCULAR BIOGENICS LTD31 citations96
US7902176B2Mar 8, 2011
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
VASCULAR BIOGENICS LTD31 citations96
US7893291B2Feb 22, 2011
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD24 citations96
US7625882B2Dec 1, 2009
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
VASCULAR BIOGENICS LTD31 citations96
US7504388B2Mar 17, 2009
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD31 citations96
US7186704B2Mar 6, 2007
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD31 citations96
US6838452B2Jan 4, 2005
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD62 citations96
US8039261B2Oct 18, 2011
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
VASCULAR BIOGENICS LTD27 citations92
US7989427B2Aug 2, 2011
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
VASCULAR BIOGENICS LTD21 citations92
US7585666B2Sep 8, 2009
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
VASCULAR BIOGENICS LTD29 citations92
US7067649B2Jun 27, 2006
Promoters exhibiting endothelial cell specificity and methods of using same
VASCULAR BIOGENICS LTD40 citations92
US7579327B2Aug 25, 2009
Promoters exhibiting endothelial cell specificity and methods of using same
VASCULAR BIOGENICS LTD23 citations91
US8916378B2Dec 23, 2014
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
VASCULAR BIOGENICS LTD4 citations83
US8859747B2Oct 14, 2014
Promoters exhibiting endothelial cell specificity and methods of using same
VASCULAR BIOGENICS LTD5 citations82
US7279459B2Oct 9, 2007
Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD2 citations63
HARATS DROR
9 patentsUS8563534B2Oct 22, 2013
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
HARATS DROR8 citations92
US8415318B2Apr 9, 2013
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
HARATS DROR14 citations92
US8158611B2Apr 17, 2012
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
HARATS DROR18 citations92
US8206743B2Jun 26, 2012
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
HARATS DROR14 citations91
US8071740B2Dec 6, 2011
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
HARATS DROR19 citations91
US8835398B2Sep 16, 2014
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
HARATS DROR6 citations83
US8501715B2Aug 6, 2013
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
HARATS DROR8 citations83
US8859745B2Oct 14, 2014
Promoters exhibiting endothelial cell specificity and methods of using same
HARATS DROR5 citations82
US8846401B2Sep 30, 2014
Promoters exhibiting endothelial cell specificity and methods of using same
HARATS DROR5 citations82